Abstract
The purpose of this study was to clarify the effects of fudosteine ((—)-(R)-2-amino-3-(3-hydroxypropylthio)propionic acid), a new mucoactive drug, on mucus secretion in the human pulmonary mucoepidermoid carcinoma cell line NCI-H292. NCI-H292 cells produced hyaluronidase-resistant high-molecular-weight glycoconjugates (HMWG), which were eluted in the void volume on Superose 6HR column chromatography. ATP, bradykinin, and methacholine increased the basal secretion of [14C]glucosamine-labelled HMWG in NCI-H292 cells. Fudosteine significantly suppressed the HMWG secretion induced by ATP or bradykinin, but not that induced by methacholine. Other mucoactive drugs, such as ethylcysteine, ambroxol and carboxymethylcysteine, did not affect the increase in HMWG. These results indicate that fudosteine suppresses the mucin secretion induced by ATP and bradykinin in airway mucus-producing cancer cells.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
